Top 5 Stock Picks of Osman Ozsan’s Deuterium Capital Management

Page 1 of 5

This article discusses Deuterium Capital Management’s top 5 stock picks at the end of June 2022. If you want to know about the fund’s history, its investment strategy, and recent performance, please also read Top 10 Stock Picks of Osman Ozsan’s Deuterium Capital Management.

05. AbbVie Inc. (NYSE:ABBV

Deuterium Capital Management’s Stake Value: $1.300 million

Percentage of Deuterium Capital Management’s 13F Portfolio: 4.4%

Number of Hedge Fund Holders as of Q1 2022: 76

AbbVie Inc. (NYSE:ABBV) was incorporated in 2012 and is headquartered in North Chicago, Illinois. It discovers, develops, manufactures, and sells pharmaceuticals worldwide.

On August 1, Atlantic Equities analyst Steve Chesney downgraded AbbVie Inc. (NYSE:ABBV) to Neutral from Overweight with a price target of $162, down from $178. The analyst says “incremental weakness” across the company’s core franchises hints at a slowing pace of upward estimate revisions. The stock is a new addition to Deuterium Capital Management’s portfolio, with a total stake value of $1.3 million (4.4% of the portfolio).

Page 1 of 5